Option Care Health, Inc. (OPCH) shareholders
Close on Nov 17, 2026Market cap $4.74BP/E 23.8Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 19,587,246 | 13.10% | 13G (passive) amendment | Sep 30, 2026 |
| Wellington Management Group LLP Joint filing with Wellington Group Holdings LLP (10.00%), Wellington Investment Advisors Holdings LLP (10.00%) and 1 more | 17,075,799 | 10.00% | 13G (passive) amendment | Nov 29, 2024 |
| Wellington Management Company LLP Joint filing with Wellington Management Group LLP (8.10%), Wellington Group Holdings LLP (8.10%) and 1 more | 13,332,168 | 7.70% | 13G (passive) amendment | Jun 30, 2025 |
| Vanguard Capital Management | 8,228,614 | 5.25% | 13G (passive) | Mar 31, 2026 |
| Vanguard Portfolio Management | 8,201,422 | 5.24% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of OPCH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 22,104,863 | 14.76% | $463.54M | +2,217,031 | 0.01% |
| Wellington Management Group Llp | 11,782,384 | 7.87% | $247.08M | −115,083 | 0.04% |
| Vanguard Portfolio Management LLC | 8,274,458 | 5.52% | $173.52M | +211,903 | 0.01% |
| Fuller & Thaler Asset Management, Inc. | 7,450,698 | 4.97% | $156.24M | +325,418 | 0.43% |
| Vanguard Capital Management LLC | 7,063,747 | 4.72% | $148.13M | +47,424 | 0.00% |
| Durable Capital Partners LP | 6,163,722 | 4.12% | $129.25M | −2,827,532 | 1.26% |
| State Street Corp | 6,139,898 | 4.10% | $128.75M | +265,018 | 0.00% |
| Arrowstreet Capital, Limited Partnership | 5,980,270 | 3.99% | $125.41M | +1,744,033 | 0.06% |
| Dimensional Fund Advisors LP | 5,449,294 | 3.64% | $114.28M | +1,572,438 | 0.02% |
| Geode Capital Management, LLC | 4,467,797 | 2.98% | $93.71M | +219,576 | 0.00% |
| Millennium Management LLC | 2,618,869 | 1.75% | $54.92M | +977,878 | 0.02% |
| Charles Schwab Investment Management Inc | 2,464,334 | 1.65% | $51.68M | −24,199 | 0.01% |
| Bank Of America Corp /De/ | 2,266,839 | 1.51% | $47.54M | +321,824 | 0.00% |
| Morgan Stanley | 2,240,837 | 1.50% | $46.99M | −573,415 | 0.00% |
| Van Berkom & Associates Inc. | 2,185,884 | 1.46% | $45.84M | −989,388 | 1.48% |
| Goldman Sachs Group Inc | 2,165,092 | 1.45% | $45.40M | +791,302 | 0.00% |
| Sumitomo Mitsui Trust Holdings, Inc. | 2,132,614 | 1.42% | $44.72M | −478,333 | 0.03% |
| Northern Trust Corp | 1,961,486 | 1.31% | $41.13M | +16,486 | 0.00% |
| Boston Partners | 1,952,275 | 1.30% | $41.00M | −479,192 | 0.04% |
| Nuveen, LLC | 1,938,948 | 1.29% | $40.66M | +318,076 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 371 | 157M | 100.0% | 79 / 131 | 124 / 73 | 23M | 33M |
| Q1 2026 | 372 | 167M | 100.0% | 64 / 134 | 130 / 51 | 34M | 21M |
| Q4 2025 | 366 | 171M | 100.0% | 62 / 122 | 142 / 71 | 24M | 18M |
| Q3 2025 | 381 | 165M | 100.0% | 68 / 137 | 138 / 60 | 18M | 16M |
| Q2 2025 | 382 | 163M | 100.0% | 55 / 145 | 146 / 54 | 19M | 18M |
| Q1 2025 | 384 | 163M | 100.0% | 85 / 128 | 139 / 41 | 24M | 24M |
| Q4 2024 | 345 | 164M | 100.0% | 84 / 121 | 109 / 75 | 25M | 35M |
| Q3 2024 | 339 | 174M | 100.0% | 50 / 121 | 124 / 52 | 40M | 20M |
| Q2 2024 | 342 | 175M | 100.0% | 58 / 131 | 117 / 55 | 19M | 19M |
| Q1 2024 | 341 | 175M | 100.0% | 36 / 148 | 115 / 42 | 16M | 13M |
| Q4 2023 | 351 | 174M | 100.0% | 59 / 134 | 124 / 61 | 28M | 25M |
| Q3 2023 | 356 | 171M | 100.0% | 74 / 153 | 87 / 33 | 26M | 27M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
404 funds held OPCH in Q2 2026, 48% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of OPCH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fullerthaler Behavioral Small Cap Equity | 7,157,244 | 4.78% | $150.09M | 1.19% | Jun 30, 2026 |
| Vanguard Health Care Fund | 6,748,598 | 4.51% | $155.42M | 0.41% | Jul 31, 2026 |
| iShares Core S&P Mid-Cap ETF | 5,368,727 | 3.58% | $112.58M | 0.09% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 4,979,416 | 3.32% | $104.42M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 4,097,807 | 2.74% | $85.93M | 0.10% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 3,604,513 | 2.41% | $75.59M | 0.04% | Jun 30, 2026 |
| Vanguard Explorer Fund | 2,181,430 | 1.46% | $50.24M | 0.23% | Jul 31, 2026 |
| Vanguard Small-Cap Growth Index Fund | 2,075,999 | 1.39% | $43.53M | 0.09% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,801,462 | 1.20% | $37.78M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,744,742 | 1.16% | $40.18M | 0.12% | Jul 31, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 1,582,208 | 1.06% | $33.18M | 0.57% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 1,200,600 | 0.80% | $25.18M | 0.16% | Jun 30, 2026 |
| Touchstone Strategic Trust-Touchstone Small Company Fund | 1,020,918 | 0.68% | $21.41M | 1.25% | Jun 30, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 942,590 | 0.63% | $19.77M | 0.17% | Jun 30, 2026 |
| U.S. Small Cap Portfolio | 925,945 | 0.62% | $21.32M | 0.11% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John Charles Rademacher | Chief Executive Officer, Director | 695,152 | 0.46% | May 4, 2026 |
| Prateek Bhatia | EVP Sp Sales & Solutions | 16,386 | 0.01% | Jul 8, 2026 |
| Collin Smyser | GC & Corporate Secretary | 77,512 | 0.05% | May 21, 2026 |
| Meenal Sethna | Chief Financial Officer | 98,337 | 0.07% | May 4, 2026 |
| Femi Adewunmi | Chief Medical Officer | 25,314 | 0.02% | Apr 24, 2026 |
| Michael Bavaro | Chief Human Resources Officer | 33,249 | 0.02% | Mar 3, 2026 |
| Christopher L. Grashoff | Chief Growth Officer | 44,092 | 0.03% | Feb 26, 2026 |
| Luke Whitworth | Chief Operating Officer | 169,589 | 0.11% | Feb 26, 2026 |
| Nicole Maggio | Chief Accounting Officer | 28,489 | 0.02% | Feb 26, 2026 |
| Michael H. Shapiro | Chief Financial Officer | 311,933 | 0.21% | Feb 26, 2025 |
| R. Carter Pate | Director | 14,128 | 0.01% | Nov 12, 2026 |
| Timothy P. Sullivan | Director | 82,380 | 0.05% | May 22, 2026 |
| Harry M. Jansen Kraemer Jr | Director | 458,997 | 0.31% | May 22, 2026 |
| Norman L. Wright | Director | 24,498 | 0.02% | May 22, 2026 |
| Elizabeth D. Bierbower | Director | 32,871 | 0.02% | May 22, 2026 |
| Eric Brandt | Director | 19,356 | 0.01% | May 22, 2026 |
| Natasha Deckmann | Director | 32,002 | 0.02% | May 22, 2026 |
| Barbara W. Bodem | Director | 21,087 | 0.01% | May 22, 2026 |
| David W. Golding | Director | 116,525 | 0.08% | Aug 21, 2025 |
| Elizabeth Quadros Betten | Director | 29,216 | 0.02% | May 19, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| R. Carter Pate Director | Nov 11, 2026 | Sale | −400 | $31.65 | $12.66K | 14,128 |
| R. Carter Pate Director | Nov 10, 2026 | Sale | −6,092 | $31.65 | $192.81K | 14,528 |
| Prateek Bhatia EVP Sp Sales & Solutions | Jul 6, 2026 | Award | +16,386 | – | – | 16,386 |
| Prateek Bhatia EVP Sp Sales & Solutions | Jul 6, 2026 | Award | +23,409 | – | – | 39,795 |
| Natasha Deckmann Director | May 20, 2026 | Award | +844 | $22.23 | $18.76K | 32,002 |
| Natasha Deckmann Director | May 20, 2026 | Award | +8,997 | – | – | 31,158 |
| Timothy P. Sullivan Director | May 20, 2026 | Award | +8,997 | – | – | 82,380 |
| Timothy P. Sullivan Director | May 20, 2026 | Award | +4,836 | $22.23 | $107.50K | 87,216 |
| Harry M. Jansen Kraemer Jr Director | May 20, 2026 | Award | +8,997 | – | – | 458,997 |
| Harry M. Jansen Kraemer Jr Director | May 20, 2026 | Award | +12,079 | $22.23 | $268.52K | 471,076 |
| Elizabeth D. Bierbower Director | May 20, 2026 | Award | +8,997 | – | – | 32,871 |
| Norman L. Wright Director | May 20, 2026 | Award | +8,997 | – | – | 24,498 |
| Eric Brandt Director | May 20, 2026 | Award | +8,997 | – | – | 19,356 |
| Eric Brandt Director | May 20, 2026 | Award | +2,643 | $22.23 | $58.75K | 21,999 |
| Barbara W. Bodem Director | May 20, 2026 | Award | +8,997 | – | – | 21,087 |
| R. Carter Pate Director | May 20, 2026 | Award | +8,997 | – | – | 20,620 |
| Collin Smyser GC & Corporate Secretary | May 19, 2026 | Tax withholding | −360 | $20.86 | $7.51K | 75,012 |
| Collin Smyser GC & Corporate Secretary | May 19, 2026 | Option exercise | +812 | – | – | 75,372 |
| Timothy P. Sullivan Director | May 7, 2026 | Buy | +24,154 | $20.69 | $499.75K | 73,383 |
| Harry M. Jansen Kraemer Jr Director | May 4, 2026 | Buy | +36,610 | $21.41 | $783.82K | 450,000 |
| John Charles Rademacher Chief Executive Officer, Director | May 4, 2026 | Buy | +12,500 | $21.18 | $264.75K | 695,152 |
| Meenal Sethna Chief Financial Officer | May 4, 2026 | Buy | +16,225 | $20.16 | $327.10K | 98,337 |
| Femi Adewunmi Chief Medical Officer | Apr 22, 2026 | Tax withholding | −1,396 | $28.38 | $39.62K | 25,314 |
| R. Carter Pate Director | Feb 27, 2026 | Sale | −30,287 | $32.05 | $970.70K | 11,623 |
| Michael Bavaro Chief Human Resources Officer | Feb 27, 2026 | Sale | −6,000 | $33.00 | $198.00K | 33,249 |
| Luke Whitworth Chief Operating Officer | Feb 24, 2026 | Tax withholding | −4,605 | $33.82 | $155.74K | 169,589 |
| John Charles Rademacher Chief Executive Officer, Director | Feb 24, 2026 | Tax withholding | −11,050 | $33.82 | $373.71K | 682,652 |
| Michael Bavaro Chief Human Resources Officer | Feb 24, 2026 | Tax withholding | −1,354 | $33.82 | $45.79K | 39,249 |
| Femi Adewunmi Chief Medical Officer | Feb 24, 2026 | Tax withholding | −1,627 | $33.82 | $55.03K | 26,710 |
| Collin Smyser GC & Corporate Secretary | Feb 24, 2026 | Tax withholding | −2,210 | $33.82 | $74.74K | 74,560 |
| Nicole Maggio Chief Accounting Officer | Feb 24, 2026 | Tax withholding | −975 | $33.82 | $32.97K | 28,489 |
| Christopher L. Grashoff Chief Growth Officer | Feb 24, 2026 | Tax withholding | −1,980 | $33.82 | $66.96K | 44,092 |
| Luke Whitworth Chief Operating Officer | Feb 22, 2026 | Tax withholding | −24,029 | $35.69 | $857.60K | 174,194 |
| Collin Smyser GC & Corporate Secretary | Feb 22, 2026 | Tax withholding | −15,433 | $35.69 | $550.80K | 76,770 |
| John Charles Rademacher Chief Executive Officer, Director | Feb 22, 2026 | Tax withholding | −132,848 | $35.69 | $4.74M | 693,702 |
| Michael Bavaro Chief Human Resources Officer | Feb 22, 2026 | Tax withholding | −12,212 | $35.69 | $435.85K | 40,603 |
| Nicole Maggio Chief Accounting Officer | Feb 22, 2026 | Tax withholding | −372 | $35.69 | $13.28K | 29,464 |
| Christopher L. Grashoff Chief Growth Officer | Feb 22, 2026 | Tax withholding | −538 | $35.69 | $19.20K | 46,072 |
| John Charles Rademacher Chief Executive Officer, Director | Feb 21, 2026 | Tax withholding | −4,956 | $35.69 | $176.88K | 826,550 |
| John Charles Rademacher Chief Executive Officer, Director | Feb 21, 2026 | Option exercise | +11,087 | – | – | 831,506 |
| Luke Whitworth Chief Operating Officer | Feb 20, 2026 | Tax withholding | −4,015 | $35.69 | $143.30K | 198,223 |
| Collin Smyser GC & Corporate Secretary | Feb 20, 2026 | Tax withholding | −2,012 | $35.69 | $71.81K | 92,203 |
| John Charles Rademacher Chief Executive Officer, Director | Feb 20, 2026 | Tax withholding | −10,638 | $35.69 | $379.67K | 820,419 |
| Michael Bavaro Chief Human Resources Officer | Feb 20, 2026 | Tax withholding | −1,187 | $35.69 | $42.36K | 52,815 |
| Nicole Maggio Chief Accounting Officer | Feb 20, 2026 | Tax withholding | −619 | $35.69 | $22.09K | 29,836 |
| Christopher L. Grashoff Chief Growth Officer | Feb 20, 2026 | Tax withholding | −1,948 | $35.69 | $69.52K | 46,610 |
| Collin Smyser GC & Corporate Secretary | Feb 18, 2026 | Award | +15,213 | – | – | 94,215 |
| John Charles Rademacher Chief Executive Officer, Director | Feb 18, 2026 | Award | +78,876 | – | – | 831,057 |
| Luke Whitworth Chief Operating Officer | Feb 18, 2026 | Award | +30,423 | – | – | 202,238 |
| Meenal Sethna Chief Financial Officer | Feb 18, 2026 | Award | +27,045 | – | – | 82,112 |
| Nicole Maggio Chief Accounting Officer | Feb 18, 2026 | Award | +4,226 | – | – | 30,455 |
| Femi Adewunmi Chief Medical Officer | Feb 18, 2026 | Award | +9,579 | – | – | 28,337 |
| Michael Bavaro Chief Human Resources Officer | Feb 18, 2026 | Award | +9,579 | – | – | 54,002 |
| Christopher L. Grashoff Chief Growth Officer | Feb 18, 2026 | Award | +12,678 | – | – | 48,558 |
| Luke Whitworth Chief Operating Officer | Feb 17, 2026 | Tax withholding | −508 | $35.24 | $17.90K | 171,815 |
| Nicole Maggio Chief Accounting Officer | Feb 17, 2026 | Tax withholding | −247 | $35.24 | $8.70K | 26,229 |
| Michael Bavaro Chief Human Resources Officer | Feb 17, 2026 | Tax withholding | −551 | $35.24 | $19.42K | 44,423 |
| Christopher L. Grashoff Chief Growth Officer | Feb 17, 2026 | Tax withholding | −259 | $35.24 | $9.13K | 35,880 |
| Harry M. Jansen Kraemer Jr Director | Nov 3, 2025 | Buy | +38,000 | $25.98 | $987.24K | 413,390 |
| Meenal Sethna Chief Financial Officer | Oct 1, 2025 | Award | +55,067 | – | – | 55,067 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Option Care Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,065 shares on Oct 8, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Robert C Pate Director | Nov 10, 2026 | 6,492 | $207.75K | Nov 10, 2026 | Stock Award |
| Michael Bavaro Officer | Feb 27, 2026 | 6,000 | $198.00K | Feb 27, 2026 | Stock Award |
| R. Carter Pate Director | Feb 26, 2026 | 30,287 | $965.85K | Feb 26, 2026 | Open Market |
| Michael Bavaro Officer | Feb 28, 2025 | 30,996 | $1.03M | Feb 28, 2025 | stock award |
| Michael H. Shapiro Officer | Aug 22, 2024 | 23,217 | $743.00K | Aug 22, 2024 | stock award |
| Elizabeth Quadros Betten Director | Aug 21, 2024 | 47,531 | $1.52M | Aug 21, 2024 | stock award |
| Timothy P. Sullivan Director | Aug 21, 2024 | 47,249 | $1.46M | Aug 22, 2024 | Restricted Stock |
| Michael Bavaro Officer | Aug 15, 2024 | 5,765 | $184.48K | Aug 15, 2024 | stock award |
| Michael Bavaro Officer | Feb 28, 2024 | 1,984 | $63.50K | Feb 28, 2024 | stock award |
| Walgreens Boots Alliance, Inc. Affiliate | Jun 8, 2023 | 10,771,926 | $331.56M | Jun 8, 2023 | Merger of HC Group Holdings I, LLC and its wholly owned subsidiary HC Group Holdings II, Inc. with and into a wholly-owned subsidiary of BioScrip, Inc. (which was rebranded as Option Care Health, Inc. |
Congress trades
4 trades in Option Care Health reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Lisa McClain MI09 · spouse | Sold | Oct 31, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Sold | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Sep 25, 2025 | $1K–15K | Oct 22, 2025 |
See a number that looks wrong?